Randall Treffy

Dr. Randall Treffy

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Mechanisms of Development
Verified
Journal Article
Closed access
KGKristin L. Gallik
Kristin L. Gallik
RTRandall Treffy
Randall Treffy
LNLynne M. Nacke
Lynne M. Nacke
KAKamil Ahsan
Kamil Ahsan
MRManuel Rocha
Manuel Rocha
ASAnkur Saxena
Ankur Saxena

2 July 2023 in Heliyon
Verified
Journal Article
Open access
RTRandall Treffy
Randall Treffy
BLBrandon Laing
Brandon Laing
Akram M ErakyAkram M Eraky
Akram M Eraky
SSSaman Shabani
Saman Shabani
Infections of the spine are an ever-increasing health concern requiring an often complex and prolonged treatment that can lead to significant morbidity. Of particular interest is the cervical spine where there is an increase rate of post-infectious deformity, secondary neurological deficits and substantially higher rates of associated morbidity and mortality than the thoracic or lumbar spine. In this review, we explore the diagnosis and treatment of spondylodiscitis with particular focus on the cervical spine.

15 May 2023 in Journal of Integrative Neuroscience
Verified
Journal Article
Open access
PDF file
Akram M ErakyAkram M Eraky
Akram M Eraky
RBRyan T. Beck
Ryan T. Beck
RTRandall Treffy
Randall Treffy
DADaniel M. Aaronson
Daniel M. Aaronson
HHHirad Hedayat
Hirad Hedayat
Lesions of the central nervous system (CNS) can present with numerous and overlapping radiographical and clinical features that make diagnosis difficult based exclusively on history, physical examination, and traditional imaging modalities. Given that there are significant differences in optimal treatment protocols for these various CNS lesions, rapid and non-invasive diagnosis could lead to improved patient care. Recently, various advanced magnetic resonance imaging (MRI) techniques showed promising methods to differentiate between various tumors and lesions that conventional MRI cannot define by comparing their physiologic characteristics, such as vascularity, permeability, oxygenation, and metabolism. These advanced MRI techniques include dynamic susceptibility contrast MRI (DSC), diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, Golden-Angle Radial Sparse Parallel imaging (GRASP), Blood oxygen level-dependent functional MRI (BOLD fMRI), and arterial spin labeling (ASL) MRI. In this article, a narrative review is used to discuss the current trends in advanced MRI techniques and potential future applications in identifying difficult-to-distinguish CNS lesions. Advanced MRI techniques were found to be promising non-invasive modalities to differentiate between paraganglioma, schwannoma, and meningioma. They are also considered promising methods to differentiate gliomas from lymphoma, post-radiation changes, pseudoprogression, demyelination, and metastasis. Advanced MRI techniques allow clinicians to take advantage of intrinsic biological differences in CNS lesions to better identify the etiology of these lesions, potentially leading to more effective patient care and a decrease in unnecessary invasive procedures. More clinical studies with larger sample sizes should be encouraged to assess the significance of each advanced MRI technique and the specificity and sensitivity of each radiologic parameter.

2 April 2016 in Developmental Neuroscience
Verified
Journal Article
Closed access
PDF file
RTRandall Treffy
Randall Treffy
DCDavid Collins
David Collins
NHNatalia Hoshino
Natalia Hoshino
STSon Ton
Son Ton
GKGennadiy Aleksandrovich Katsevman
Gennadiy Aleksandrovich Katsevman
MRMichael William Rochlin
Michael William Rochlin
The innervation of taste buds is an excellent model system for studying the guidance of axons during targeting because of their discrete nature and the high fidelity of innervation. The pregustatory epithelium of fungiform papillae is known to secrete diffusible axon guidance cues such as BDNF and Sema3A that attract and repel, respectively, geniculate ganglion axons during targeting, but diffusible factors alone are unlikely to explain how taste axon terminals are restricted to their territories within the taste bud. Nondiffusible cell surface proteins such as Ephs and ephrins can act as receptors and/or ligands for one another and are known to control axon terminal positioning in several parts of the nervous system, but they have not been studied in the gustatory system. We report that ephrin-B2 linked β-galactosidase staining and immunostaining was present along the dorsal epithelium of the mouse tongue as early as embryonic day 15.5 (E15.5), but was not detected at E14.5, when axons first enter the epithelium. Ephrin-B1 immunolabeling was barely detected in the epithelium and found at a somewhat higher concentration in the mesenchyme subjacent to the epithelium. EphB1 and EphB2 were detected in lingual sensory afferents in vivo and geniculate neurites in vitro. Ephrin-B1 and ephrin-B2 were similarly effective in repelling or suppressing outgrowth by geniculate neurites in vitro. These in vitro effects were independent of the neurotrophin used to promote outgrowth, but were reduced by elevated levels of laminin. In vivo, mice null for EphB1 and EphB2 exhibited decreased gustatory innervation of fungiform papillae. These data provide evidence that ephrin-B forward signaling is necessary for normal gustatory innervation of the mammalian tongue.

14 March 2023 in World Neurosurgery
Verified
Journal Article
Closed access
EHEdward Harwick
Edward Harwick
ISIshan Singhal
Ishan Singhal
BCBrian Conway
Brian Conway
WMWade Mueller
Wade Mueller
RTRandall Treffy
Randall Treffy
MKMax Krucoff
Max Krucoff

2 January 2025 in Cancers
Verified
Journal Article
Open access
PDF file
RGRyan Gough
Ryan Gough
RTRandall Treffy
Randall Treffy
MKMax Krucoff
Max Krucoff
ADand Rupen Desai
and Rupen Desai
Glioblastoma is the most common primary brain tumor in adult patients, and despite standard-of-care treatment, median survival has remained less than two years. Advances in our understanding of molecular mutations have led to changes in the diagnostic criteria of glioblastoma, with the WHO classification integrating important mutations into the grading system in 2021. We sought to review the basics of the important genetic mutations associated with glioblastoma, including known mechanisms and roles in disease pathogenesis/treatment. We also examined new advances in image processing as well as less invasive and noninvasive diagnostic tools that can aid in the diagnosis and surveillance of those undergoing treatment for glioblastoma. Our review is intended to serve as an overview of the current state-of-the-art in the diagnosis and management of glioblastoma.